Omnicell Builds Out its Medication Synchronization Platform

People with chronic medical conditions typically take a lot of medications, and it’s not uncommon that many of them skip or forget to take some of their meds as prescribed. A 2011 survey released by the National Consumers League projected that the number of Americans affected by at least one chronic condition requiring medication therapy […]

The Market for PBMs Slows in 2016

Magellan Health, Inc. (NASDAQ: MGLN), a healthcare management company specializing in special populations and pharmacy benefits management, has just acquired privately held Veridicus Holdings, LLC. The sellers are Gauge Capital, company management and other unnamed backers. Based in Salt Lake City, Veridicus is a pharmacy benefit management (PBM) company that uses proprietary software to integrate […]

Community Health Systems Starts Divesting Hospitals

It’s no secret that Community Health Systems (NYSE: CYH) has a $15 billion debt load, and that despite its spin-off of Quorum Health Corp. (NYSE: QHC) last April, its financial performance hasn’t improved. During the company’s third-quarter earnings call on November 1, CEO Wayne Smith said the company was in discussions to shed 17 of its […]

WellCare Health Adds Universal American for $800 Million

WellCare Health Plan (NYSE: WCG) breathed a little life into the lethargic Managed Care sector, which has experienced a lull in M&A this year. WellCare provides government-sponsored managed care services, and its target, Universal American Corp. (NYSE: UAM), provides health insurance and managed care products and services to Medicare and Medicaid customers in the United […]

CROs Are Back, Many with Specialties

We’ve documented the increase in biotechnology acquisitions and license deals by pharmaceutical companies in previous posts. But the impact of pharma’s move away from in-house R&D has benefited other sectors of the healthcare industry, particularly clinical research organizations (CROs). For those outside the technology side of healthcare, CROs provide outsourced research services to the pharmaceutical, […]

November Sees a Surge in Lab Deals

Four deals in our Laboratories, MRI & Dialysis sector have been announced in the first half of November. That much activity constitutes a surge for this sector, which now stands at 39 deals through all of 2016. With only six weeks left in the year, it seems unlikely that this sector will surpass 2015’s total of 52 […]

What U.S. Hospitals Are Acquiring in 2016

Hospital acquisitions have surged since the Affordable Care Act was passed in 2010. That year, 76 deals were announced, with a U.S. hospital or health system as a target. By 2012, 107 transactions were recorded for hospital targets, and that still stands as the highest number of deals per year. Only 2015 came close, with 102 hospital transactions. […]

Boston Scientific Seeks Out Portfolio Acquisitions

Earlier this year, Boston Scientific Corporation (NYSE: BSX) acquired two companies: Cosman Medical Inc. to strengthen its neuromodulation business and EndoChoice Holdings Inc. to strengthen its pathology services and imaging technologies. Since then, the medical device giant has toned down its acquiring habits with two asset/portfolio purchases in November. On November 3, 2016, the company acquired the […]